Weekly Research Analysts’ Ratings Updates for Option Care Health (OPCH)

A number of research firms have changed their ratings and price targets for Option Care Health (NASDAQ: OPCH):

• 12/22/2025 – Option Care Health had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 12/15/2025 – Option Care Health had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 12/14/2025 – Option Care Health was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 12/11/2025 – Option Care Health was upgraded by analysts at Stephens to a “strong-buy” rating.
• 12/10/2025 – Option Care Health is now covered by analysts at Stephens. They set an “overweight” rating and a $40.00 price target on the stock.
• 12/9/2025 – Option Care Health had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $31.00 to $36.00. They now have a “buy” rating on the stock.
• 12/9/2025 – Option Care Health had its price target raised by analysts at Bank of America Corporation from $32.00 to $35.00. They now have a “buy” rating on the stock.
• 12/8/2025 – Option Care Health had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 12/6/2025 – Option Care Health was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.
• 11/25/2025 – Option Care Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/19/2025 – Option Care Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/15/2025 – Option Care Health was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 11/13/2025 – Option Care Health had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings.
• 11/3/2025 – Option Care Health had its price target lowered by analysts at TD Cowen from $30.00 to $27.00. They now have a “hold” rating on the stock.
• 10/31/2025 – Option Care Health was given a new $36.00 price target on by analysts at JMP Securities.
• 10/31/2025 – Option Care Health had its “outperform” rating reaffirmed by analysts at Citigroup Inc..
• 10/31/2025 – Option Care Health had its “outperform” rating reaffirmed by analysts at Barrington Research. They now have a $38.00 price target on the stock.
• 10/31/2025 – Option Care Health had its price target lowered by analysts at Citizens Jmp from $38.00 to $36.00. They now have a “market outperform” rating on the stock.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 38,000 shares of Option Care Health stock in a transaction that occurred on Monday, November 3rd. The stock was bought at an average price of $25.98 per share, with a total value of $987,240.00. Following the completion of the purchase, the director owned 413,390 shares in the company, valued at approximately $10,739,872.20. The trade was a 10.12% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 0.64% of the company’s stock.

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.